InMed Pharmaceuticals Inc. (INM)
NASDAQ · Healthcare
InMed Pharmaceuticals Inc. Revenue 2021–2025
InMed Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2021 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- InMed Pharmaceuticals Inc. revenue for the quarter ending December 31, 2025 was 820188, a 26.22% decrease year-over-year.
- InMed Pharmaceuticals Inc. revenue for the twelve months ending December 31, 2025 was 4.3 M, a 5.80% decrease year-over-year.
- InMed Pharmaceuticals Inc. annual revenue for 2025 was 4.9 M, a 7.50% increase from 2024.
- InMed Pharmaceuticals Inc. annual revenue for 2024 was 4.6 M, a 11.18% increase from 2023.
- InMed Pharmaceuticals Inc. annual revenue for 2023 was 4.1 M, a 202.80% increase from 2022.
- InMed Pharmaceuticals Inc. annual revenue for 2022 was 1.4 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
InMed Pharmaceuticals Inc. Market Cap — FAQ
InMed Pharmaceuticals Inc. (INM) market cap over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see INM's market cap history?
The chart and table above show InMed Pharmaceuticals Inc.'s market cap by year and by quarter, including the growth rate.